Assessment of Real World HER2 Status by Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) in Breast Cancers: Comparison with HERmark, a Validated Quantitative Measure of HER2 Protein Expression.

被引：0
|
作者：
Huang, W. [1 ]
Paquet, A. [1 ]
Sivaraman, S. [1 ]
Pesano, R. [1 ]
Goodman, L. [1 ]
Sherwood, T. [1 ]
Lie, Y. [1 ]
Hickey, J. [1 ]
Walworth, C. [1 ]
Haddad, M. [1 ]
Andersonl, S. [1 ]
Bates, M. [1 ]
Weidler, J. [1 ]
机构：
[1] Monogram Biosci Inc, San Francisco, CA USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/0008-5472.SABCS11-P1-07-12
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1-07-12
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Comparison of Chromogenic in Situ Hybridisation (CISH) with Immunohistochemistry (IHC) for the Detection of HER2 Status in Breast Cancer
    Desai, S.
    Shirsat, H.
    Epari, S.
    Bagal, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2009, 11 (06): : 659 - 660
  • [32] HER2 status in invasive breast cancer: Immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization
    Shirsat, Hemlata S.
    Epari, Sridhar
    Shet, Tanuja
    Bagal, Rajani
    Hawaldar, Rohini
    Desai, Sangeeta B.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2012, 55 (02) : 175 - 179
  • [33] Concordance between immunohistochemistry and FISH(fluorescence in sity hybridization) & SISH(silver in situ hybridization) for assessment of the HER2
    Lee, M-R
    Cho, S-H
    Kim, D-C
    Lee, K-C
    Lee, J-H
    Kwon, H-C
    Lee, H-W
    Lee, S-E
    CANCER RESEARCH, 2012, 72
  • [34] Quantitative image analysis (QIA) of HER2 immunohistochemistry (IHC) provides a reproducible, accurate, and cost-effective tool for HER2 assessment of breast cancers
    Judd, R. L.
    MODERN PATHOLOGY, 2007, 20 : 37A - 37A
  • [35] Quantitative image analysis (QIA) of HER2 immunohistochemistry (IHC) provides a reproducible, accurate, and cost-effective tool for HER2 assessment of breast cancers
    Judd, R. L.
    LABORATORY INVESTIGATION, 2007, 87 : 37A - 37A
  • [36] Comparison of IHC and FISH Results of HER2 Oncogene Status in Breast Cancer
    Yelenich-Huss, Mallory J.
    Patel, Herschel
    Janning, Kaitlynn
    Ray, Ashley Griffin
    Ogola, Gerald
    Waddimba, Anthony
    Grant, Michael
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 2) : S293 - S294
  • [37] HER2 amplification: Correlation of chromogenic in situ hybridization (CISH) with inummohistochemistry (IHC) and fluorescence in situ hybridization (FISH)
    Wixom, CR
    Albers, EA
    Weidner, N
    MODERN PATHOLOGY, 2003, 16 (01) : 51A - 51A
  • [38] Comparison of fluorescence in situ hybridization (FISH) and chromogenic in situ hybridization (CISH) for assessment of HER2 gene amplification in breast cancer
    Bhargava, R
    Lal, P
    Salazar, PA
    Chen, B
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (02): : 151 - 151
  • [39] Her2/neu amplification in breast carcinoma: Comparison of real-time quantitative polymerase chain reaction (PCR), immunohistochemistry (IHC) and fluorescent in situ hybridization (FISH)
    Smolkin, MB
    Mahadevia, P
    Vuolo, M
    Ramesh, KH
    Cannizzaro, L
    Ratech, H
    Schultz, C
    MODERN PATHOLOGY, 2003, 16 (01) : 48A - 48A
  • [40] Her2/neu amplification in breast carcinoma: Comparison of real-time quantitative polymerase chain reaction (PCR), immunohistochemistry (IHC) and flourescent in situ hybridization (FISH)
    Smolkin, MB
    Mahadevia, P
    Vuolo, M
    Ramesh, KH
    Cannizzaro, L
    Ratech, H
    Schultz, C
    LABORATORY INVESTIGATION, 2003, 83 (01) : 48A - 48A
12345